S6:E5 – Oncology Morning Commute: Targeted Therapies for Gastroesophageal and Colorectal Cancers

Hematology / Oncology @Point of Care Podcasts

English - February 28, 2022 22:00 - 22 minutes - 30.5 MB
Medicine Health & Fitness checkpointinhibitors cmece endometrialcancer immunotherapy Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: S6:E4 – Oncology Morning Commute: Targeting HER2, HER3, and TROP2 in NSCLC

Next Episode: S6:E6 – Oncology Morning Commute: The Emerging Role for Antibody-Drug Conjugates in GI Cancers

HER2 expression in gastric/gastroesophageal junction and colorectal cancer potentially paves the way for the use of targeted therapies for these cancers. Our faculty discuss these important clinical developments.

Visit www.morningcommutepodcast.com/solidtumors5 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit